Pentazoctyl hydrochloride

盐酸喷他佐辛酯

Report date: 2022/03/10 10:40:00
NME

Base Information

Drug NamePentazoctyl hydrochloride
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKappa opioid receptor agonistsSigma opioid receptor agonistsMu opioid receptor agonists +[4] 
TargetsKappa opioid receptorSigma opioid receptorMu opioid receptor
Therapy Area/IndicationsCancer Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHorgos Inviting Moon Consulting Co LtdJinzhou Aohong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJinzhou Aohong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCancer Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A